Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Bone Diseases, Metabolic × Zoledronic Acid × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 2 Lymphoid 1 Genitourinary 1

Conditions

Prostatic Neoplasms 44 Neoplasm Metastasis 11 Carcinoma, Renal Cell 6 Breast Neoplasms 5 Pain 4 Osteoporosis 4 Neoplasms 3 Kidney Neoplasms 3 Multiple Myeloma 2 Urologic Neoplasms 1 Lung Neoplasms 1 Insulin Resistance 1 Clear-cell metastatic renal cell carcinoma 1 Bone Diseases, Metabolic 1

Interventions

Zoledronic Acid 1 Toremifene 1 Nutrition Assessment 1 Denosumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00181584 2013-07-11

Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer

Massachusetts General Hospital

Phase 2 Completed

Bone Diseases, Metabolic, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡